首页 > 最新文献

Journal of Experimental Therapeutics and Oncology最新文献

英文 中文
Intraoperative MRI for resection of intracranial meningiomas. 术中MRI在颅内脑膜瘤切除术中的应用。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Shamik Chakraborty, Salvatore Zavarella, Sussan Salas, Michael Schulder

Objective: To examine whether intraoperative MRI can enhance safety and extent of resection of complex intracranial meningiomas, given its positive role in the resection of malignant brain tumors and pituitary tumors.

Methods: Over a ten-year period, 70 operations were performed on 66 patients with intracranial meningiomas using the compact, mobile PoleStar N20 iMRI navigation system. A retrospective review was conducted examining patient demographics, surgical characteristics, and outcomes.

Results: 36 meningiomas were above the skull base and 30 were of the skull base. Four (5.7%) operations were done for recurrent meningiomas. 63 patients (95.5%) had WHO grade I and 3 patients (4.5%) had WHO grade III meningiomas. 9 (12.8%) patients required additional tumor resection based on iMRI findings, and in 4 patients (6%) iMRI imaging allowed for avoidance of additional dissection near critical neurovascular structures.

Conclusions: Up to 15.7% of patients had surgery positively affected by intraoperative imaging either improving the resection or avoiding unnecessary additional dissection which could potentially harm critical neurologic structures. As iMRI becomes more widely available it may be valuable to use in an appropriate subset of patients with intracranial meningiomas.

目的:探讨术中MRI在恶性脑肿瘤及垂体肿瘤切除术中的积极作用,是否能提高复杂颅内脑膜瘤切除术的安全性和范围。方法:采用紧凑、移动的PoleStar N20 iMRI导航系统对66例颅内脑膜瘤患者进行了70例手术。回顾性分析了患者的人口统计学特征、手术特点和结果。结果:颅底以上脑膜瘤36例,颅底脑膜瘤30例。复发性脑膜瘤手术4例(5.7%)。WHO I级脑膜瘤63例(95.5%),WHO III级脑膜瘤3例(4.5%)。9例(12.8%)患者需要根据iMRI发现进行额外的肿瘤切除,4例(6%)患者iMRI成像允许避免在关键神经血管结构附近进行额外的解剖。结论:术中影像改善了手术切除或避免了不必要的额外解剖,避免了对关键神经系统结构的潜在损害,对手术有积极影响的患者高达15.7%。随着iMRI的应用越来越广泛,在颅内脑膜瘤患者的适当亚群中使用它可能是有价值的。
{"title":"Intraoperative MRI for resection of intracranial meningiomas.","authors":"Shamik Chakraborty,&nbsp;Salvatore Zavarella,&nbsp;Sussan Salas,&nbsp;Michael Schulder","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To examine whether intraoperative MRI can enhance safety and extent of resection of complex intracranial meningiomas, given its positive role in the resection of malignant brain tumors and pituitary tumors.</p><p><strong>Methods: </strong>Over a ten-year period, 70 operations were performed on 66 patients with intracranial meningiomas using the compact, mobile PoleStar N20 iMRI navigation system. A retrospective review was conducted examining patient demographics, surgical characteristics, and outcomes.</p><p><strong>Results: </strong>36 meningiomas were above the skull base and 30 were of the skull base. Four (5.7%) operations were done for recurrent meningiomas. 63 patients (95.5%) had WHO grade I and 3 patients (4.5%) had WHO grade III meningiomas. 9 (12.8%) patients required additional tumor resection based on iMRI findings, and in 4 patients (6%) iMRI imaging allowed for avoidance of additional dissection near critical neurovascular structures.</p><p><strong>Conclusions: </strong>Up to 15.7% of patients had surgery positively affected by intraoperative imaging either improving the resection or avoiding unnecessary additional dissection which could potentially harm critical neurologic structures. As iMRI becomes more widely available it may be valuable to use in an appropriate subset of patients with intracranial meningiomas.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer treatment and management for elderly patients 80 years of age or older with malignant solid tumors. 80岁及以上老年恶性实体瘤患者的肿瘤治疗与管理。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Mao Matsubayashi, Fumihiro Oshita, Natsuki Kawata, Takafumi Yanagibashi, Satoshi Tanaka, Yoshiteru Hao, Yuichi Kurakami, Keisuke Iwabuchi, Yohsuke Kunishi, Mitsuyasu Ohta, Yuki Nakamura, Kohichiro Yoshie

Objective: We retrospectively analyzed the backgrounds, treatment and nursing care for 96 patients aged 80 years or more with malignant tumors. Twenty of them were hospitalized on an emergency basis. Sixty patients were male and 36 were female, with a median age of 83 years (range: 80-94 years). Twenty-seven had a PS of 3 or 4, and 41 were rated as not independent based on analysis of autonomy at hospitalization. Forty-seven patients had clinical stage III or IV malignancies. The proportions of patients with disease complications were 33.3% for neurological disease, 21.9% for respiratory disease, 70.8% for cardiovascular disease including hypertension, and 36.5% for metabolic disease. Thirty-nine patients underwent surgical or endoscopic resection of their tumors. Twenty-three patients received chemotherapy: hormonal treatment in 14, local injection of cytotoxic agent(s) in 6 and systemic anti-cancer therapy in 3. Thirty-nine patients received supportive care only. Forty-three patients newly required nursing care or an increased level of care at discharge. The median survival time was 10.9 and 15.3 months for stage III/IV and 0/I/II patients, respectively. In conclusion, most elderly patients with malignant tumors require full supportive care, including social nursing care, from the time of cancer diagnosis.

目的:回顾性分析96例80岁以上恶性肿瘤患者的背景、治疗及护理。其中20人被紧急送往医院。男性60例,女性36例,中位年龄83岁(范围80-94岁)。27例患者的PS为3或4分,41例患者在住院时的自主性分析中被评为不独立。47例患者有临床III期或IV期恶性肿瘤。其中,神经系统疾病占33.3%,呼吸系统疾病占21.9%,包括高血压在内的心血管疾病占70.8%,代谢性疾病占36.5%。39例患者接受手术或内镜切除肿瘤。23例患者接受化疗:激素治疗14例,局部注射细胞毒药物6例,全身抗癌治疗3例。39例患者仅接受支持性治疗。43例患者在出院时需要护理或提高护理水平。III/IV期和0/I/II期患者的中位生存时间分别为10.9和15.3个月。综上所述,大多数老年恶性肿瘤患者从癌症诊断开始就需要充分的支持性护理,包括社会护理。
{"title":"Cancer treatment and management for elderly patients 80 years of age or older with malignant solid tumors.","authors":"Mao Matsubayashi,&nbsp;Fumihiro Oshita,&nbsp;Natsuki Kawata,&nbsp;Takafumi Yanagibashi,&nbsp;Satoshi Tanaka,&nbsp;Yoshiteru Hao,&nbsp;Yuichi Kurakami,&nbsp;Keisuke Iwabuchi,&nbsp;Yohsuke Kunishi,&nbsp;Mitsuyasu Ohta,&nbsp;Yuki Nakamura,&nbsp;Kohichiro Yoshie","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>We retrospectively analyzed the backgrounds, treatment and nursing care for 96 patients aged 80 years or more with malignant tumors. Twenty of them were hospitalized on an emergency basis. Sixty patients were male and 36 were female, with a median age of 83 years (range: 80-94 years). Twenty-seven had a PS of 3 or 4, and 41 were rated as not independent based on analysis of autonomy at hospitalization. Forty-seven patients had clinical stage III or IV malignancies. The proportions of patients with disease complications were 33.3% for neurological disease, 21.9% for respiratory disease, 70.8% for cardiovascular disease including hypertension, and 36.5% for metabolic disease. Thirty-nine patients underwent surgical or endoscopic resection of their tumors. Twenty-three patients received chemotherapy: hormonal treatment in 14, local injection of cytotoxic agent(s) in 6 and systemic anti-cancer therapy in 3. Thirty-nine patients received supportive care only. Forty-three patients newly required nursing care or an increased level of care at discharge. The median survival time was 10.9 and 15.3 months for stage III/IV and 0/I/II patients, respectively. In conclusion, most elderly patients with malignant tumors require full supportive care, including social nursing care, from the time of cancer diagnosis.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35573607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment. 不同肽组合对提高促性腺激素释放激素疫苗治疗前列腺癌免疫原性的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Franklin Fuentes Aguilar, Jesús Junco Barranco, Lesvia Calzada Aguilera, Eddy Bover Fuentes, Jose André Serradelo Leal, Eduardo Hernández López, Eulogio Pimentel Vázquez, Roberto Basulto Baker, Osvaldo Reyes Acosta, Hilda Garay Pérez, Gerardo Guillén Nieto

Purpose: Therapeutic vaccines, specifically the Gonadotrophin Releasing Hormone (GnRH) vaccine, are considered an additional therapeutic option for advanced stage prostate cancer. Our work showed amplification of the immune response when combining two peptides with and without the Very Small Size Proteoliposomes (VSSP). VSSP is a potent adjuvant for dendritic cells activation and Th1 differentiation. as enhanced immune response.

Methods: The test was carried out in Copenhagen rats as animal model.

Resultst: The use of both peptides and their combination with VSSP generated a potentiation of the immune response statistically superior, in term of generating anti GnRH antibody and effects on target organs, when it was compared with the effects which occurs with independent peptides and with and without the VSSP. These results can find application in the development of GnRH vaccine candidates and in peptide based vaccine strategies.

Conclusions: Immunization with the peptide combination enhances the immune response when mixed with the VSSPs.

目的:治疗性疫苗,特别是促性腺激素释放激素(GnRH)疫苗,被认为是晚期前列腺癌的额外治疗选择。我们的研究表明,当两种多肽与非常小尺寸蛋白脂质体(VSSP)结合或不结合时,免疫反应会扩增。VSSP是树突状细胞活化和Th1分化的有效佐剂。增强免疫反应。方法:以哥本哈根大鼠为动物模型进行实验。结果:在产生抗GnRH抗体和对靶器官的作用方面,与单独使用多肽和不使用VSSP相比,使用两种多肽及其与VSSP联合使用对免疫反应的增强具有统计学上的优势。这些结果可以在GnRH候选疫苗的开发和基于肽的疫苗策略中找到应用。结论:多肽联合免疫与vsps混合可增强免疫应答。
{"title":"The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment.","authors":"Franklin Fuentes Aguilar,&nbsp;Jesús Junco Barranco,&nbsp;Lesvia Calzada Aguilera,&nbsp;Eddy Bover Fuentes,&nbsp;Jose André Serradelo Leal,&nbsp;Eduardo Hernández López,&nbsp;Eulogio Pimentel Vázquez,&nbsp;Roberto Basulto Baker,&nbsp;Osvaldo Reyes Acosta,&nbsp;Hilda Garay Pérez,&nbsp;Gerardo Guillén Nieto","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Purpose: </strong>Therapeutic vaccines, specifically the Gonadotrophin Releasing Hormone (GnRH) vaccine, are considered an additional therapeutic option for advanced stage prostate cancer. Our work showed amplification of the immune response when combining two peptides with and without the Very Small Size Proteoliposomes (VSSP). VSSP is a potent adjuvant for dendritic cells activation and Th1 differentiation. as enhanced immune response.</p><p><strong>Methods: </strong>The test was carried out in Copenhagen rats as animal model.</p><p><strong>Resultst: </strong>The use of both peptides and their combination with VSSP generated a potentiation of the immune response statistically superior, in term of generating anti GnRH antibody and effects on target organs, when it was compared with the effects which occurs with independent peptides and with and without the VSSP. These results can find application in the development of GnRH vaccine candidates and in peptide based vaccine strategies.</p><p><strong>Conclusions: </strong>Immunization with the peptide combination enhances the immune response when mixed with the VSSPs.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35626584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly efficient destruction of squamous carcinoma cells of the head and neck by photochemical internalization of Ranpirnase. Ranpirnase光化学内化对头颈部鳞状癌细胞的高效破坏。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Nora Liebers, Tim Holland-Letz, Mona Welschof, Anders Høgset, Dirk Jäger, Michaela A E Arndt, Jürgen Krauss

Introduction: Photochemical Internalization is a novel drug delivery technology for cancer treatment based on the principle of Photodynamic Treatment. Using a photosensitizer that locates in endocytic vesicles membranes of tumor cells, Photochemical internalization enables cytosolic release of endocytosed antitumor agents in a site-specific manner. The purpose of the present in-vitro study was to explore whether Photochemical Internalization is able to enhance the efficacy of Ranpirnase, a cytotoxic amphibian ribonuclease, for eradication of squamous cell carcinoma of the head and neck.

Methods: Cell viability was measured in 8 primary human cell lines of squamous cell carcinoma of the head and neck after treatment with Ranpirnase and Photochemical Internalization. For Photochemical Internalization the photosensitizer disulfonated tetraphenyl porphine was incubated with tumor cells followed by exposure to blue light (435 nm).

Results: Our study demonstrates significant enhancement of antitumor activity of Ranpirnase by Photochemical Internalization. Treatment responses were heterogeneous between the primary cancer cell lines. Combining Photochemical Internalization with Ranpirnase resulted in 4.6 to 1,940-fold increased cytotoxicity when compared with the ribonuclease alone (P < 0.05).

Conclusion: Cytotoxicity of Ranpirnase can be markedly enhanced by Photochemical Internalization in squamous cell carcinoma of the head and neck.

光化学内化是一种基于光动力治疗原理的新型肿瘤给药技术。利用位于肿瘤细胞内吞囊泡膜上的光敏剂,光化学内化使内吞抗肿瘤药物以特定部位的方式在胞质内释放。本体外研究的目的是探讨光化学内化是否能够提高Ranpirnase(一种细胞毒性两栖动物核糖核酸酶)根除头颈部鳞状细胞癌的疗效。方法:用Ranpirnase和光化学内化治疗8株人头颈部鳞状细胞癌,测定细胞活力。为了光化学内化,将光敏剂二磺酸四苯基卟啉与肿瘤细胞一起孵育,然后暴露于蓝光(435 nm)下。结果:光化学内化能显著增强Ranpirnase的抗肿瘤活性。原发癌细胞系之间的治疗反应是不均匀的。与单独使用核糖核酸酶相比,光化学内化与Ranpirnase联合使用的细胞毒性增加了4.6 ~ 1940倍(P < 0.05)。结论:光化学内化可显著增强Ranpirnase在头颈部鳞状细胞癌中的细胞毒性。
{"title":"Highly efficient destruction of squamous carcinoma cells of the head and neck by photochemical internalization of Ranpirnase.","authors":"Nora Liebers,&nbsp;Tim Holland-Letz,&nbsp;Mona Welschof,&nbsp;Anders Høgset,&nbsp;Dirk Jäger,&nbsp;Michaela A E Arndt,&nbsp;Jürgen Krauss","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Photochemical Internalization is a novel drug delivery technology for cancer treatment based on the principle of Photodynamic Treatment. Using a photosensitizer that locates in endocytic vesicles membranes of tumor cells, Photochemical internalization enables cytosolic release of endocytosed antitumor agents in a site-specific manner. The purpose of the present in-vitro study was to explore whether Photochemical Internalization is able to enhance the efficacy of Ranpirnase, a cytotoxic amphibian ribonuclease, for eradication of squamous cell carcinoma of the head and neck.</p><p><strong>Methods: </strong>Cell viability was measured in 8 primary human cell lines of squamous cell carcinoma of the head and neck after treatment with Ranpirnase and Photochemical Internalization. For Photochemical Internalization the photosensitizer disulfonated tetraphenyl porphine was incubated with tumor cells followed by exposure to blue light (435 nm).</p><p><strong>Results: </strong>Our study demonstrates significant enhancement of antitumor activity of Ranpirnase by Photochemical Internalization. Treatment responses were heterogeneous between the primary cancer cell lines. Combining Photochemical Internalization with Ranpirnase resulted in 4.6 to 1,940-fold increased cytotoxicity when compared with the ribonuclease alone (P < 0.05).</p><p><strong>Conclusion: </strong>Cytotoxicity of Ranpirnase can be markedly enhanced by Photochemical Internalization in squamous cell carcinoma of the head and neck.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-based design and evaluation of synthetic porphyrin derivatives as G-quadruplex stabilizing anticancer agents. 基于结构的合成卟啉衍生物g -四联体稳定抗癌剂的设计与评价。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
R N Bhadane, D B Meshram, R M Gilhotra

Objective: G-quadruplex structures formed in telomeres and proto-oncogene represent a potentially useful target for anticancer drugs. Stabilization of this arrangement may inhibit the further action of different enzymes involved in cancer cell immortalization. In present work structure based drug design and synthesis was carried out on series of meso-substituted porphyrin analogues. The interaction of porphyrin derivatives with G-quadruplex DNA has been explored by virtual screening procedure. Some of the potential binding agents were then synthesized and evaluated in-vitro by MTT and PCR stop assay. The study indicates that these compounds had strong G-Quadruplex binding affinity with very good inhibitory activity in MCF-7 and A549 cell lines.

目的:在端粒和原癌基因中形成的g -四重体结构是抗癌药物潜在的有用靶点。这种排列的稳定可能会抑制参与癌细胞永生的不同酶的进一步作用。目前的工作是基于结构的药物设计和合成一系列中位取代卟啉类似物。卟啉衍生物与g -四重体DNA的相互作用已通过虚拟筛选程序进行了探索。然后合成了一些潜在的结合剂,并通过MTT和PCR停止实验对其进行了体外评价。研究表明,这些化合物对MCF-7和A549细胞株具有很强的g -四重体结合亲和力,具有很好的抑制活性。
{"title":"Structure-based design and evaluation of synthetic porphyrin derivatives as G-quadruplex stabilizing anticancer agents.","authors":"R N Bhadane,&nbsp;D B Meshram,&nbsp;R M Gilhotra","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>G-quadruplex structures formed in telomeres and proto-oncogene represent a potentially useful target for anticancer drugs. Stabilization of this arrangement may inhibit the further action of different enzymes involved in cancer cell immortalization. In present work structure based drug design and synthesis was carried out on series of meso-substituted porphyrin analogues. The interaction of porphyrin derivatives with G-quadruplex DNA has been explored by virtual screening procedure. Some of the potential binding agents were then synthesized and evaluated in-vitro by MTT and PCR stop assay. The study indicates that these compounds had strong G-Quadruplex binding affinity with very good inhibitory activity in MCF-7 and A549 cell lines.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of relationship of ABO blood groups among tobacco induced oral cancer patients of Kanpur Population, Uttar Pradesh. 对北方邦坎普尔人口中烟草诱发的口腔癌患者的 ABO 血型关系进行评估。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Gayathri Ramesh, Anuradha Katiyar, Amrita Raj, Amit Kumar, Ramesh Nagarajappa, Amit Pandey

Background: The possibility of association between ABO blood groups and malignancy was first discussed by Anderson DE & Haas C. The association between blood group and oral cancer is least explored and hence this study was undertaken to evaluate relationship of ABO blood groups with an increased risk for oral cancer.

Materials and method: The present study was conducted at various cancer hospitals in Kanpur. The study samples comprised 100 oral cancer patients and 50 controls with tobacco chewing habit. The information regarding the socio demographic profile, history on tobacco habits, type of oral cancer and ABO blood group profile was obtained from the case sheets of the patients.

Results: The frequency of squamous cell carcinoma was significantly higher in men (78%) than women (22%) and mostly found in the age range of 45-65 years and also consuming chewing type of tobacco. It was found that out of 100 patients, 53 were of blood group B+ve, 28 of O +ve, 16 of A+ve and 3 had the blood group AB+ve. The high potential risk of developing OSCC was more in B+ve blood group (1.96 times), and relative frequency (%) in blood group O+ve (1.64 times) than in the control group Among locations of oral cancers, squamous cell carcinoma of tongue (25%) and buccal mucosa (15%) was more common in B+ve and Carcinoma of floor of mouth (11%) was more common in O+ve blood group cases. It was found that people with blood group B+ve, followed by O+ve had increased risk of developing OSCC with most prevalent being Well Differentiated OSCC as compared to people of other blood groups.

Conclusion: The present study reveals that there is an inherited element in the susceptibility against different types of oral cancers. The people with blood group B+ve and O+ve having tobacco chewing habits can be appraised that they are more at risk to develop oral cancer than people with other blood groups.

背景:安德森(Anderson DE)和哈斯(Haas C)首次讨论了 ABO 血型与恶性肿瘤之间可能存在的联系,但对血型与口腔癌之间的联系探讨最少,因此本研究旨在评估 ABO 血型与口腔癌风险增加之间的关系:本研究在坎普尔的多家癌症医院进行。研究样本包括 100 名口腔癌患者和 50 名有咀嚼烟草习惯的对照组。从患者的病例表中获取了有关社会人口学概况、烟草习惯史、口腔癌类型和 ABO 血型概况的信息:结果:男性患鳞状细胞癌的比例(78%)明显高于女性(22%),且多见于 45-65 岁年龄段的人群和有咀嚼烟草习惯的人群。研究发现,在 100 名患者中,53 人的血型为 B+ve,28 人的血型为 O+ve,16 人的血型为 A+ve,3 人的血型为 AB+ve。与对照组相比,B+ve 血型患者罹患口腔癌的潜在风险更高(1.96 倍),O+ve 血型患者罹患口腔癌的相对频率(%)更高(1.64 倍)。在口腔癌的发病部位中,B+ve 血型患者更常见的是舌鳞癌(25%)和口腔黏膜鳞癌(15%),而 O+ve 血型患者更常见的是口底癌(11%)。研究发现,与其他血型的人相比,B+ve 血型的人患 OSCC 的风险更高,其次是 O+ve 血型的人,最常见的是分化良好的 OSCC:本研究揭示了不同类型口腔癌的易感性存在遗传因素。与其他血型的人相比,有咀嚼烟草习惯的 B+ve 和 O+ve 血型的人患口腔癌的风险更高。
{"title":"Assessment of relationship of ABO blood groups among tobacco induced oral cancer patients of Kanpur Population, Uttar Pradesh.","authors":"Gayathri Ramesh, Anuradha Katiyar, Amrita Raj, Amit Kumar, Ramesh Nagarajappa, Amit Pandey","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The possibility of association between ABO blood groups and malignancy was first discussed by Anderson DE & Haas C. The association between blood group and oral cancer is least explored and hence this study was undertaken to evaluate relationship of ABO blood groups with an increased risk for oral cancer.</p><p><strong>Materials and method: </strong>The present study was conducted at various cancer hospitals in Kanpur. The study samples comprised 100 oral cancer patients and 50 controls with tobacco chewing habit. The information regarding the socio demographic profile, history on tobacco habits, type of oral cancer and ABO blood group profile was obtained from the case sheets of the patients.</p><p><strong>Results: </strong>The frequency of squamous cell carcinoma was significantly higher in men (78%) than women (22%) and mostly found in the age range of 45-65 years and also consuming chewing type of tobacco. It was found that out of 100 patients, 53 were of blood group B+ve, 28 of O +ve, 16 of A+ve and 3 had the blood group AB+ve. The high potential risk of developing OSCC was more in B+ve blood group (1.96 times), and relative frequency (%) in blood group O+ve (1.64 times) than in the control group Among locations of oral cancers, squamous cell carcinoma of tongue (25%) and buccal mucosa (15%) was more common in B+ve and Carcinoma of floor of mouth (11%) was more common in O+ve blood group cases. It was found that people with blood group B+ve, followed by O+ve had increased risk of developing OSCC with most prevalent being Well Differentiated OSCC as compared to people of other blood groups.</p><p><strong>Conclusion: </strong>The present study reveals that there is an inherited element in the susceptibility against different types of oral cancers. The people with blood group B+ve and O+ve having tobacco chewing habits can be appraised that they are more at risk to develop oral cancer than people with other blood groups.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micronuclei assay in exfoliated buccal cells of radiation treated oral cancer patients. 放射治疗口腔癌患者口腔脱落细胞的微核测定。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Gayathri Ramesh, Smriti Chaubey, Amrita Raj, Ravi Kumar Seth, Anuradha Katiyar, Amit Kumar

Background: Micronuclei are suitable internal dosimeters for revealing tissue-specific genotoxic damage in individuals exposed to carcinogenic mixtures. Evaluation of radiation-induced cellular changes to predict radiosensitivity has invested many investigators since such changes were first found in biopsy material.

Aim: The aim of the present study was to assess the relationship of with histopathological grade and number of radiation therapy sittings with the frequency of micronuclei and nuclear anomalies among oral cancer patients.

Material & method: Thirty male patients with histologically proven cases of oral cancer undergoing radiation therapy and age and sex matched 20 healthy controls were included in the study. Scrape cytology smears of exfoliated buccal cells were prepared and stained using Feulgen stain and frequency of micronuclei and other nuclear anomalies counts were evaluated with the help of light microscope expressed as per 1000 buccal cells.

Results: The mean values of the micronuclei and nuclear anomalies were 14.03 and 21.30 respectively. There was a significant association and strong positive correlation of Radiation exposure and grades of squamous cell carcinoma with micronuclei and nuclear anomalies. There was no statistically significant association and correlation between nuclear anomalies in well differentiated and moderately differentiated carcinomas.

Conclusion: With increase number of radiation therapy sittings, there was increase in number of micronuclei and nuclear anomalies. Hence the result of this study highlights that increased number of micronuclei and nuclear anomalies provides information regarding radiosensitivity of epithelial cells.

背景:微核是揭示暴露于致癌物混合物的个体的组织特异性基因毒性损伤的合适的内剂量计。自从这种变化首次在活检材料中发现以来,评估辐射诱导的细胞变化以预测放射敏感性已经投入了许多研究人员。目的:探讨口腔癌患者微核及核异常发生频率与组织病理分级及放疗次数的关系。材料与方法:选取30例经组织学证实接受放射治疗的男性口腔癌患者,年龄和性别与20例健康对照相匹配。制备脱落的颊细胞刮片,用Feulgen染色,光镜下每1000个颊细胞表达微核频率及其他核异常计数。结果:微核平均值为14.03,核异常平均值为21.30。辐射暴露与鳞状细胞癌分级与微核及核异常有显著的正相关关系。高分化癌和中分化癌的核异常无统计学意义。结论:随着放射治疗次数的增加,微核和核异常的数量增加。因此,本研究结果强调,微核和核异常数量的增加提供了有关上皮细胞放射敏感性的信息。
{"title":"Micronuclei assay in exfoliated buccal cells of radiation treated oral cancer patients.","authors":"Gayathri Ramesh,&nbsp;Smriti Chaubey,&nbsp;Amrita Raj,&nbsp;Ravi Kumar Seth,&nbsp;Anuradha Katiyar,&nbsp;Amit Kumar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Micronuclei are suitable internal dosimeters for revealing tissue-specific genotoxic damage in individuals exposed to carcinogenic mixtures. Evaluation of radiation-induced cellular changes to predict radiosensitivity has invested many investigators since such changes were first found in biopsy material.</p><p><strong>Aim: </strong>The aim of the present study was to assess the relationship of with histopathological grade and number of radiation therapy sittings with the frequency of micronuclei and nuclear anomalies among oral cancer patients.</p><p><strong>Material & method: </strong>Thirty male patients with histologically proven cases of oral cancer undergoing radiation therapy and age and sex matched 20 healthy controls were included in the study. Scrape cytology smears of exfoliated buccal cells were prepared and stained using Feulgen stain and frequency of micronuclei and other nuclear anomalies counts were evaluated with the help of light microscope expressed as per 1000 buccal cells.</p><p><strong>Results: </strong>The mean values of the micronuclei and nuclear anomalies were 14.03 and 21.30 respectively. There was a significant association and strong positive correlation of Radiation exposure and grades of squamous cell carcinoma with micronuclei and nuclear anomalies. There was no statistically significant association and correlation between nuclear anomalies in well differentiated and moderately differentiated carcinomas.</p><p><strong>Conclusion: </strong>With increase number of radiation therapy sittings, there was increase in number of micronuclei and nuclear anomalies. Hence the result of this study highlights that increased number of micronuclei and nuclear anomalies provides information regarding radiosensitivity of epithelial cells.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral submucous fibrosis: an etiological dilemma. 口腔黏膜下纤维化:一个病因困境。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Aanchal Sharma, Rajesh Kumar, Navdeep Johar, Husain Sabir

Objective: Oral Submucous Fibrosis (OSF), is a well-recognized, oral potentially malignant disorder predominantly affecting the South- Asian countries. OSF causes unique generalized fibrosis of the submucosal oral soft tissues, resulting in marked rigidity of the oral mucosa leading to progressive inability to open the mouth, rigidity of lips and difficulty in protruding the tongue. In this review we have discussed the multifactorial etiology of this potentially malignant disorder, including Chillies, Nutritional Deficiencies, Inducible nitric oxide synthsis (iNOS), genetic and immunological predisposition; and most importantly the role of areca nut and the effect of copper content in it.

目的:口腔粘膜下纤维化(OSF)是一种公认的口腔潜在恶性疾病,主要影响南亚国家。OSF引起口腔粘膜下软组织独特的全身性纤维化,导致口腔黏膜明显僵硬,进行性无法张开嘴巴,嘴唇僵硬,舌头难以伸出。在这篇综述中,我们讨论了这种潜在恶性疾病的多因素病因,包括辣椒,营养缺乏,诱导型一氧化氮合成(iNOS),遗传和免疫易感性;最重要的是槟榔果的作用和其中铜含量的影响。
{"title":"Oral submucous fibrosis: an etiological dilemma.","authors":"Aanchal Sharma,&nbsp;Rajesh Kumar,&nbsp;Navdeep Johar,&nbsp;Husain Sabir","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Oral Submucous Fibrosis (OSF), is a well-recognized, oral potentially malignant disorder predominantly affecting the South- Asian countries. OSF causes unique generalized fibrosis of the submucosal oral soft tissues, resulting in marked rigidity of the oral mucosa leading to progressive inability to open the mouth, rigidity of lips and difficulty in protruding the tongue. In this review we have discussed the multifactorial etiology of this potentially malignant disorder, including Chillies, Nutritional Deficiencies, Inducible nitric oxide synthsis (iNOS), genetic and immunological predisposition; and most importantly the role of areca nut and the effect of copper content in it.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35573604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer Cell Controller. 癌细胞控制器。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Sunil Kumar Kashyap, Vikas Kumar Jain, Swati Jain, Ashutosh Pandey

Objective: Cancer is the disease which exists when the cell is uncontrolled. This paper presents a controller for the same. The cancer cell is reviewed via algebraic structures.

目的:肿瘤是细胞不受控制而存在的疾病。本文提出了一种控制器。癌细胞是通过代数结构来研究的。
{"title":"Cancer Cell Controller.","authors":"Sunil Kumar Kashyap,&nbsp;Vikas Kumar Jain,&nbsp;Swati Jain,&nbsp;Ashutosh Pandey","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Cancer is the disease which exists when the cell is uncontrolled. This paper presents a controller for the same. The cancer cell is reviewed via algebraic structures.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness on cytology procedure in oral cancer detection among undergraduates: An institutional study. 大学生口腔癌细胞学检查意识的机构研究。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-01
Gayathri Ramesh, Rajeev Pathak, Sunita Pathak, Amrita Raj, Amit Kumar, Anuradha Katiyar

Background: The screening and the early detection of the premalignant and malignant lesions are the only means for controlling the oral cancer which is known to be one of the leading causes for mortality worldwide. Oral exfoliative cytology though not a substitute for biopsy can be a powerful tool for its early detection. Dental Surgeons can play a great role in this direction.

Aims and objectives: The present study was undertaken to assess the self-reported knowledge and attitude regarding the early detection of oral cancer and exfoliative cytology among the undergraduates of Rama Dental College, Kanpur.

Material and methods: A pretested questionnaire based cross sectional study consisting of twenty four questions was conducted among hundred randomly selected students from third year, final year and intern's batch.

Results: According to 73% of students biopsy was the special test done in oral cancer detection and only 59% had heard regarding oral cytology technique. Formalin was the fixative known for cytology smears among 61%. Significance of toluidine blue staining was not known by 62%. Seventy seven percent of students were not aware about classes of cytology reporting. Eighty six percent of students felt that the adequacy of training in cytology was lagging.

Conclusion: This survey identified an existing gap in the knowledge among the dental students regarding cytology as a diagnostic aid in oral cancer detection. This emphasizes the need to provide training for undergraduates at clinical level on regular basis and also through CDE and oral can-cer detection workshops.

背景:口腔癌是世界范围内死亡的主要原因之一,对其进行筛查和早期发现是控制口腔癌的唯一手段。口腔剥脱细胞学虽然不能代替活检,但可以作为早期检测的有力工具。牙科医生在这方面可以发挥很大的作用。目的和目的:本研究旨在评估坎普尔拉玛牙科学院本科生对早期发现口腔癌和剥脱细胞学的自我报告知识和态度。材料与方法:采用预测问卷的横断面研究方法,随机抽取三年级、四年级和实习生共100名学生,共24个问题。结果:73%的学生活检是口腔癌检测中的一项特殊检查,仅有59%的学生听说过口腔细胞学技术。福尔马林是61%的细胞学涂片已知的固定剂。62%的人不知道甲苯胺蓝染色的意义。77%的学生不知道细胞学报告课程。86%的学生认为细胞学培训的充分性滞后。结论:本调查发现齿科学生对细胞学作为口腔癌诊断辅助手段的认识存在差距。这强调需要定期为临床水平的本科生提供培训,并通过CDE和口腔癌检测讲习班进行培训。
{"title":"Awareness on cytology procedure in oral cancer detection among undergraduates: An institutional study.","authors":"Gayathri Ramesh,&nbsp;Rajeev Pathak,&nbsp;Sunita Pathak,&nbsp;Amrita Raj,&nbsp;Amit Kumar,&nbsp;Anuradha Katiyar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The screening and the early detection of the premalignant and malignant lesions are the only means for controlling the oral cancer which is known to be one of the leading causes for mortality worldwide. Oral exfoliative cytology though not a substitute for biopsy can be a powerful tool for its early detection. Dental Surgeons can play a great role in this direction.</p><p><strong>Aims and objectives: </strong>The present study was undertaken to assess the self-reported knowledge and attitude regarding the early detection of oral cancer and exfoliative cytology among the undergraduates of Rama Dental College, Kanpur.</p><p><strong>Material and methods: </strong>A pretested questionnaire based cross sectional study consisting of twenty four questions was conducted among hundred randomly selected students from third year, final year and intern's batch.</p><p><strong>Results: </strong>According to 73% of students biopsy was the special test done in oral cancer detection and only 59% had heard regarding oral cytology technique. Formalin was the fixative known for cytology smears among 61%. Significance of toluidine blue staining was not known by 62%. Seventy seven percent of students were not aware about classes of cytology reporting. Eighty six percent of students felt that the adequacy of training in cytology was lagging.</p><p><strong>Conclusion: </strong>This survey identified an existing gap in the knowledge among the dental students regarding cytology as a diagnostic aid in oral cancer detection. This emphasizes the need to provide training for undergraduates at clinical level on regular basis and also through CDE and oral can-cer detection workshops.</p>","PeriodicalId":45335,"journal":{"name":"Journal of Experimental Therapeutics and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35627062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Experimental Therapeutics and Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1